Home›People›Brian Longstreet
Brian Longstreet

Brian Longstreet

Chief Executive Officer and director at Illuminare Biotechnologies.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Jun 4, 2026·Suggest an edit

About Brian Longstreet

Brian Longstreet is a chief executive officer and director at Illuminare Biotechnologies.

Experience

This experience comes from Brian Longstreet's profile and from SEC filings. For roles taken from filings, the years are when the filings name Brian Longstreet in the role, so the role may have started earlier or lasted longer.

Illuminare Biotechnologies Inc Current
Chief Executive Officer and director
2026 – Present · Brooklyn, NY
Develops an injectable imaging agent to help surgeons see nerves during operations.
Exolvo Biosciences Current
Board Member
2024 – Present
LHA BioPharma Consulting
Principal
2019 – 2026
CorriXR Therapeutics
Chief Operating Officer
2022 – 2023
Diverse Biotech
Chief Executive Officer
2019 – 2021
Orexigen Therapeutics
Senior Vice President
2016 – 2018
Merck
Managing Director, Global Health Innovation Investment Fund
2009 – 2016
Schering-Plough Pharmaceuticals
Vice President, US Managed Markets – Healthcare Systems
1989 – 2009

Key Colleagues at Startups

The people Brian Longstreet works with at each company, as listed on that company's latest Form D.

Illuminare Biotechnologies Inc · Form D, Jun 4, 2026
EA
Ezra Angrist
Financial Consultant
Oliver Curme
Oliver Curme
Director
Walter Greenblatt
Walter Greenblatt
Chief Financial Officer and director
Eric Edidin
Eric Edidin
Director
AF
Shay Grinfeld
Shay Grinfeld
Director and promoter
RG
Robert Graifman
Director and promoter

Sources

  1. SECIlluminare Biotechnologies Inc Form D, filed Jun 4, 2026